Journal
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Volume 34, Issue 4, Pages 449-461Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/00952990802082198
Keywords
-
Categories
Ask authors/readers for more resources
Random controlled trials on the efficacy of naltrexone and acamprosate in the treatment of alcohol dependence were reviewed, using a Relative Benefit (RB) analysis approach. A total of 42 studies were included, showing acamprosate use demonstrated a modest improvement, with a RB of 1.76 at three month follow-up. Short-term administration of naltrexone significantly reduced the relapse rate, but was not associated with modification in the abstinence rate. There was insufficient data available to ascertain the efficacy of naltrexone and acamprosate over prolonged periods of time, or the effectiveness of the medications relative to each other.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available